Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ardelyx, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ARDX
Nasdaq
2834
www.ardelyx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ardelyx, Inc.
Ardelyx (ARDX) Reports Q2 Loss, Lags Revenue Estimates
- Aug 6th, 2026 5:10 pm
Ardelyx Q2 Earnings Call Highlights
- Aug 6th, 2026 4:04 pm
Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update
- Aug 6th, 2026 2:05 pm
Indivior Pharmaceuticals Inc. (INDV) Q2 Earnings and Revenues Beat Estimates
- Aug 3rd, 2026 5:45 am
Will Ardelyx (ARDX) Report Negative Earnings Next Week? What You Should Know
- Jul 30th, 2026 8:00 am
New Cross-Study Analysis from Spherix Global Insights Combines Physician, Dietitian and Patient Chart Data to Show Access Barriers Still Curbing Xphozah Uptake Ahead of the TDAPA Cliff
- Jul 29th, 2026 8:46 am
New Strong Sell Stocks for July 29th
- Jul 29th, 2026 3:29 am
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
- Jul 23rd, 2026 6:01 am
New Strong Sell Stocks for July 23rd
- Jul 23rd, 2026 3:45 am
Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts
- Jul 20th, 2026 1:18 pm
ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle
- Jun 26th, 2026 3:14 pm
Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?
- Jun 24th, 2026 5:32 am
Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction
- Jun 23rd, 2026 5:03 pm
What’s Fueling Optimism Around Ardelyx, Inc. (ARDX)’s Sales and Pipeline?
- Jun 23rd, 2026 9:36 am
Ardelyx (ARDX) Stock Valuation Check After Recent Share Price Volatility
- Jun 12th, 2026 12:11 pm
Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach
- Jun 4th, 2026 6:04 am
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’
- Jun 3rd, 2026 5:52 pm
Should You Buy Ardelyx (ARDX)?
- May 30th, 2026 9:18 am
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
- May 19th, 2026 6:01 am
Ardelyx (ARDX) Is Up 10.3% After Long-Term XPHOZAH Safety Data In Dialysis Patients - What's Changed
- May 9th, 2026 9:11 am
Scroll